Divis Laboratories Quarterly Results for Trading Insights
In Mar 2026, Divis Laboratories (DIVISLAB) reported revenue ₹2,986 Cr and net profit ₹751 Cr — revenue +11.8% YoY. For annual financials, live price and key ratios, visit Divis Laboratories share price today.
DIVISLAB Quarterly Results — Revenue, Profit & EPS Highlights
Divis Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore DIVISLAB price movement history to track price trends across different timeframes.
- Revenue of ₹2,986 Cr in Mar 2026 (+4.4% vs Sept 2025, +11.8% vs Mar 2025)
- Net Profit of ₹751 Cr in Mar 2026 (+9.0% vs Sept 2025, +13.4% vs Mar 2025)
- EBITDA of ₹1,089 Cr in Mar 2026 (+5.4% vs Sept 2025)
- Operating Margin of 33.0% in Mar 2026 (+0.0pp vs Sept 2025)
- Earnings Per Share of ₹28.31 in Mar 2026 (+9.0% vs Sept 2025)
Divis Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS
DIVISLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 2,986 | 2,860 | 2,671 | 2,529 | 2,692 | 4.4% | 11.8% |
| Net Profit (₹ Cr) | 751 | 689 | 662 | 545 | 583 | - | - |
| EBITDA (₹ Cr) | 1,089 | 1,033 | 972 | 848 | 904 | - | - |
| EPS (₹) | 28.31 | 25.97 | 24.93 | 20.49 | 21.98 | - | - |
| Operating Margin (%) | 33.0% | 33.0% | 34.0% | 30.0% | 31.0% | - | - |
DIVISLAB Share Price Trend — 1-Year Movement Across Quarterly Results
Divis Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Browse DIVISLAB income statement for revenue, profit, balance sheet and cash flow data.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
DIVISLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Divis Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹469,405.89 Cr | 1941.1 | 15,018 | 2,710 | +1.0% | +11.8% | 18.0% | 171.8 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹191,454.40 Cr | 4961.5 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 431.1 |
|
Zydus Life Science
Mar 2026 |
₹115,616.29 Cr | 1108.7 | 7,569 | 1,341 | +23.1% | +18.8% | 17.7% | 87.6 |
|
Cipla
Mar 2026 |
₹114,318.19 Cr | 1410.6 | 6,612 | 543 | -14.3% | -4.0% | 8.2% | 205.3 |
|
Lupin
Mar 2026 |
₹110,051.30 Cr | 2370.5 | 7,533 | 1,469 | +8.8% | +34.1% | 19.5% | 68.1 |
All amounts in ₹ Crores